Lavo Life Sciences
Winter 2023 · Active
AI for drug formulation
Founded: 2022
Team size: 3
About
Lavo Life Sciences runs simulations of drug molecules on computers. Pharma companies use these simulations to guide their experiments and ultimately save time and money in the lab. This will de-risk and expedite clinical trials and FDA approval.
Founders
Scott SwarthoutFounder
CEO of Lavo Life Sciences
Zach GlickFounder
Derek MetcalfFounder